Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trialAndreas Glenthøj, Wilma Barcellini, Hanny Al‐Samkari et al.|The Lancet Haematology|2022Cited by 49